Analysed COYA THERAPEUTICS INC (COYA:NASDAQ) News Sources
Coya Therapeutics Announces Publication Demonstrating Correlation Between Longitudinal Biomarker Data and Clinical Outcomes Supporting the Mechanistic Rationale for COYA 302 in Patients with ALS
09-04-2026
yahoo.com
Coya Therapeutics Announces Planned Board Transition and Appointment of Mark H. Pavao as Independent Director
02-04-2026
yahoo.com
Coya Therapeutics Announces Publication Demonstrating Regulatory T-Cell Dysfunction and Systemic Inflammation in Frontotemporal Dementia, Supporting Mechanistic Rationale for COYA 302 Immune-Restoring Therapy
18-03-2026
yahoo.com
Coya Therapeutics Provides a Corporate Update and Reports Fiscal 2025 Financial Results
16-03-2026
yahoo.com
Coya Therapeutics, Inc. (COYA) Upgraded to Buy: What Does It Mean for the Stock?
25-02-2026
yahoo.com
Coya Therapeutics Details ALS Combo Immunotherapy Plan, Highlights Early Biomarker Signals in Webinar
17-02-2026
marketbeat.com
Coya Therapeutics to Host Webinar with Leading Medical Experts on Amyotrophic Lateral Sclerosis (ALS) Drug Development, Patient Landscape, and Ongoing Clinical Trial
10-02-2026
yahoo.com
What is the current price of COYA THERAPEUTICS INC (COYA:NASDAQ)?
The current price of COYA THERAPEUTICS INC (COYA:NASDAQ) is $4.53.
COYA THERAPEUTICS INC (COYA:NASDAQ) absolute price change since previous trading day?
The absolute price change of COYA THERAPEUTICS INC (COYA:NASDAQ) since the previous trading day is $0.07.
COYA THERAPEUTICS INC (COYA:NASDAQ) percentage price change since previous trading day?
The percentage price change of COYA THERAPEUTICS INC (COYA:NASDAQ) since the previous trading day is 1.5695%.
What is the most recent average sentiment score for COYA THERAPEUTICS INC (COYA:NASDAQ)?
The most recent average sentiment score for COYA THERAPEUTICS INC (COYA:NASDAQ) is 83 out of 100.
What is the most recent average sentiment for COYA THERAPEUTICS INC (COYA:NASDAQ)?
The most recent sentiment for COYA THERAPEUTICS INC (COYA:NASDAQ) is .
SEC-8K** Filing Available For COYA THERAPEUTICS INC (COYA:NASDAQ)
** material developments that could impact a company's financial condition or stock price.
Author: MattELab
MattELab is the founder and lead developer of SentientMerchant. With a Computer Science and Quantitative Finance background from a T10 university, he brings over 6 years of expertise in NLP, programmatic SEO, and full-stack development to build highly scalable AI and FinTech solutions.